Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $MTSR
Metsera Inc.
Subscribe to $MTSR
$MTSR
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2025
Exchange: NASDAQ
Recent Analyst Ratings for Metsera Inc.
Date
Price Target
Rating
Analyst
6/20/2025
$65.00
Overweight
Wells Fargo
2/25/2025
$56.00
Buy
Guggenheim
2/25/2025
$38.00
Buy
BofA Securities
2/25/2025
Outperform
Evercore ISI
See more ratings
